Eleusis is a company in the clinical research phase of the life sciences field, committed to unlocking the healing potential of serotonin 2A receptor agonists, commonly known as psychedelics, by addressing and overseeing their psychoactive effects.
Eleusis
Headquarters
United Kingdom